Validation of ELDO approaches for retrospective assessment of cumulative eye lens doses of interventional cardiologists-results from DoReMi project.

The first validation results of the two approaches developed in the ELDO project for retrospective assessment of eye lens doses for interventional cardiologists (ICs) are presented in this paper. The first approach (a) is based on both the readings from the routine whole body dosimeter worn above the lead apron and procedure-dependent conversion coefficients, while the second approach (b) is based on detailed information related to the occupational exposure history of the ICs declared in a questionnaire and eye lens dose records obtained from the relevant literature. The latter approach makes use of various published eye lens doses per procedure as well as the appropriate correction factors which account for the use of radiation protective tools designed to protect the eye lens. To validate both methodologies, comprehensive measurements were performed in several Polish clinics among recruited physicians. Two dosimeters measuring whole body and eye lens doses were worn by every physician for at least two months. The estimated cumulative eye lens doses, calculated from both approaches, were then compared against the measured eye lens dose value for every physician separately. Both approaches results in comparable estimates of eye lens doses and tend to overestimate rather than underestimate the eye lens doses. The measured and estimated doses do not differ, on average, by a factor higher than 2.0 in 85% and 62% of the cases used to validate approach (a) and (b), respectively. In specific cases, however, the estimated doses differ from the measured ones by as much as a factor of 2.7 and 5.1 for method (a) and (b), respectively. As such, the two approaches can be considered accurate when retrospectively estimating the eye lens doses for ICs and will be of great benefit for ongoing epidemiological studies.

The impact of various protective tools on the dose reduction in the eye lens in an interventional cardiology-clinical study.

The aim of the study was to check, in clinical practice, the potential for the dose reduction of lead eyewear and a ceiling-suspended shield used to protect the eye lens of physicians working in interventional cardiology. To this end, for the lead eyewear, the dose reduction factors were derived to correct the readings from a dosimeter used routinely outside the glasses. Four types of lead eyewear with attached loose thermoluminescent dosimeters and EYE-D dosimeters were worn by physicians in two clinical centres, for two-month periods, during coronary angiography (CA), percutaneous coronary intervention (PCI), and pacemaker procedures. In order to analyse, separately, how a ceiling-suspended lead screen absorbs the scattered radiation, a series of measurements was carried out during single CA/PCI procedures performed with and without the protection. The lead eyewear may reduce the doses to the eye closest to the x-ray tube by a factor between 1.1 and 3.4, depending on its model and the physician's position. The effectiveness of the eyewear may, however, vary-even for the same model and physician-almost twofold between different working periods. The ceiling-suspended shield decreases the doses in clinical practice by a factor of 2.3. The annual eye lens doses without the eyewear estimated from routine measurements are high-above or close to the new eye lens dose limit established by the recent EU Basic Safety Standards, even though the ceiling-suspended shield was used. Therefore, to comply with the new dose limit that is set in the Directive, protection of the eyes of physicians with high workloads might require the use of both the eyewear and the ceiling-suspended shield.

The effectiveness of lead glasses in reducing the doses to eye lenses during cardiac implantation procedures performed using x-ray tubes above the patient table.

The dose reduction factors (DRF) for different types of lead glasses and C-arm units with x-ray tubes placed above the patient table were calculated from the results of measurements by loose thermoluminescent dosimeters (TLDs) and EYE-D dosimeters using a Rando phantom. The DRF values were analysed for different positions of routine dosimeters worn outside lead eyewear and confronted with DRFs calculated as the ratio of the dose equivalent to the eye measured with and without the eyewear. Moreover, for eye lens dosimeters designed to be worn behind lead glasses, multiplicative factors for various positions of dosimeter were derived in order to account for the differences between the doses measured on the inner side of the glasses and the dose equivalent to the eye lens. The DRFs calculated for the position of a routine dosimeter worn outside lead glasses on the band near the left eye lens are 5.6 and 5.7 for goggles and metallic glasses, respectively, while the DRFs calculated as the ratio of doses to the eyes measured with and without the eyewear are 10.2 and 9.9, respectively. Therefore, for dosimeters routinely used outside lead eyewear, the DRF calculated for the position of the dosimeter should be used. Otherwise, we can anticipate an almost two-fold underestimation of the doses. When the dosimeter is worn behind lead glasses, up to two-fold differences between the dose equivalent to the eye lens and the dose measured at the inner side of the glasses were observed depending on the dosimeter position.

Characterisation of grids of point detectors in maximum skin dose measurement in fluoroscopically-guided interventional procedures.

PURPOSE: Point detectors are frequently used to measure patient's maximum skin dose (MSD) in fluoroscopically-guided interventional procedures (IP). However, their performance and ability to detect the actual MSD are rarely evaluated. The present study investigates the sampling uncertainty associated with the use of grids of point detectors to measure MSD in IP. METHOD: Chemoembolisation of the liver (CE), percutaneous coronary intervention (PCI) and neuroembolisation (NE) procedures were studied. Spatial dose distributions were measured with XR-RV3 Gafchromic(®) films for 176 procedures. These distributions were used to simulate measurements performed using grids of detectors such as thermoluminescence detectors, with detector spacing from 1.4 up to 10 cm. RESULTS: The sampling uncertainty was the highest in PCI and NE procedures. With 40 detectors covering the film area (36 cm × 44 cm), the maximum dose would be on average 86% and 63% of the MSD measured with Gafchromic(®) films in CE and PCI procedures, respectively. In NE procedures, with 27 detectors covering the film area (14 cm × 35 cm), the maximum dose measured would be on average 82% of the MSD obtained with the Gafchromic(®) films. CONCLUSION: Thermoluminescence detectors show good energy and dose response in clinical beam qualities. However the poor spatial resolution of such point-like dosimeters may far outweigh their good dosimetric properties. The uncertainty from the sampling procedure should be estimated when point detectors are used in IP because it may lead to strong underestimation of the MSD.

Measurement of maximum skin dose in interventional radiology and cardiology and challenges in the set-up of European alert thresholds.

To help operators acknowledge patient dose during interventional procedures, EURADOS WG-12 focused on measuring patient skin dose using XR-RV3 gafchromic films, thermoluminescent detector (TLD) pellets or 2D TL foils and on investigating possible correlation to the on-line dose indicators such as fluoroscopy time, Kerma-area product (KAP) and cumulative air Kerma at reference point (CK). The study aims at defining non-centre-specific European alert thresholds for skin dose in three interventional procedures: chemoembolization of the liver (CE), neuroembolization (NE) and percutaneous coronary interventions (PCI). Skin dose values of >3 Gy (ICRP threshold for skin injuries) were indeed measured in these procedures confirming the need for dose indicators that correlate with maximum skin dose (MSD). However, although MSD showed fairly good correlation with KAP and CK, several limitations were identified challenging the set-up of non-centre-specific European alert thresholds. This paper presents preliminary results of this wide European measurement campaign and focuses on the main challenges in the definition of European alert thresholds.

The impact of x-ray tube configuration on the eye lens and extremity doses received by cardiologists in electrophysiology room.

The aim of the study was to analyse the influence of the x-ray tube configuration on the radiation doses to eye lens and extremities of cardiologists performing pacemaker implantation procedures in electrophysiology laboratory. The measurements were performed on one, widely used, portable C-arm system, first with x-ray tube mounted above the patient table and image intensifier below it and then on a reinstalled (but essentially the same) system with under-table x-ray tube configuration. Thermoluminescent dosimeters, placed in various positions near the eye lens, on the hands and ankle, were used during every procedure. The comparison of doses received by cardiologists after changing the x-ray tube configuration from over- to under-table shows statistically significant dose reduction (p < 0.009) for the eye lens closest to the x-ray tube, left finger, left wrist, while for the ankle a dose increase is observed. The corresponding over- to under-table x-ray tube median dose ratios are 4.1 for the right eye, 4.8 for the left finger, 3.0 for left wrist and, finally, 0.13 for the right ankle. Systems with under-table x-ray tube are preferable from a radiation protection point of view. The observed significant increase in doses to the legs should be partially compensated by the use of a protective lead curtain.

Extremity and eye lens doses in interventional radiology and cardiology procedures: first results of the ORAMED project.

The main objective of WP1 of the ORAMED (Optimization of RAdiation protection for MEDical staff) project is to obtain a set of standardised data on extremity and eye lens doses for staff in interventional radiology (IR) and cardiology (IC) and to optimise staff protection. A coordinated measurement program in different hospitals in Europe will help towards this direction. This study aims at analysing the first results of the measurement campaign performed in IR and IC procedures in 34 European hospitals. The highest doses were found for pacemakers, renal angioplasties and embolisations. Left finger and wrist seem to receive the highest extremity doses, while the highest eye lens doses are measured during embolisations. Finally, it was concluded that it is difficult to find a general correlation between kerma area product and extremity or eye lens doses.

Correlation of patient maximum skin doses in cardiac procedures with various dose indicators.

In most countries of European Union, legislation requires the determination of the total skin dose received by patients during interventional procedures in order to prevent deterministic damages. Various dose indicators like dose-area product (DAP), cumulative dose (CD) and entrance dose at the patient plane (EFD) are used for patient dosimetry purposes in clinical practice. This study aimed at relating those dose indicators with doses ascribed to the most irradiated areas of the patient skin usually expressed in terms of local maximal skin dose (MSD). The study was performed in two different facilities for two most common cardiac procedures coronary angiography (CA) and percutaneous coronary interventions (PCI). For CA procedures, the registered values of fluoroscopy time, total DAP and MSD were in the range (0.7-27.3) min, (16-317) Gy cm(2) and (43-1507) mGy, respectively, and for interventions, accordingly (2.1-43.6) min, (17-425) Gy cm(2), (71-1555) mGy. Moreover, for CA procedures, CD and EFD were in the ranges (295-4689) mGy and (121-1768) mGy and for PCI (267-6524) mGy and (68-2279) mGy, respectively. No general and satisfactory correlation was found for safe estimation of MSD. However, results show that the best dose indicator which might serve for rough, preliminary estimation is DAP value. In the study, the appropriate trigger levels were proposed for both facilities.

An international calibration of Kerma-Area Product meters for patient dose optimisation study.

The results of international calibration of Kerma Area Product (KAP) meters for European SENTINEL survey on patient dose optimisation of cardiac and interventional radiology practice are presented. Twelve countries were involved in the study. An investigation was conduced on 25 KAP meters fitted to undercouch X-ray tubes; 13 KAP meters were installed on cardiac units and the remaining 12 on interventional ones. The simplified calibration method has been applied, consisting of KAP estimation by multiplying the air kerma at the centre of the X-ray field by the irradiated area. The obtained values of calibration factors range from 0.4 to 0.9 and from 0.4 to 0.8 for KAP meters installed on cardiac and interventional units, respectively. They account also for table and mattress attenuation. For air kerma assessment, measurements with thermoluminescent dosemeters have been applied and when possible compared against an additional reference dosemeter. As the result of the investigation, the importance of calibration of KAP meters in clinical conditions that include mattress and table attenuation has been recognised.

Patient dose in interventional radiology: a European survey.

Patient doses for a few common fluoroscopy-guided procedures in interventional radiology (IR) (excluding cardiology) were collected from a few radiological departments in 13 European countries. The major aim was to evaluate patient doses for the basis of the reference levels. In total, data for 20 procedures for about 1300 patients were collected. There were many-fold variations in the number of IR equipment and procedures per population, in the entrance dose rates, and in the patient dose data (total dose area product or DAP, fluoroscopy time and number of frames). There was no clear correlation between the total DAP and entrance dose rate, or between the total DAP and fluoroscopy time, indicating that a number of parameters affect the differences. Because of the limited number of patients, preliminary reference levels were proposed only for a few procedures. There is a need to improve the optimisation of IR procedures and their definitions and grouping, in order to account for their different complexities.